The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary CRO and CDMO Market Research Report 2024
Synopsis
The key players operating in the animal health industry prefer contract outsourcing over in-house manufacturing, considering its associated benefits. Owing to the complex manufacturing processes of certain veterinary products, animal health drug or device manufacturers solely outsource key stages of production to expertise CROs and CDMOs. Outsourcing activities enable companies to reduce financial risk and encourage more developments & research in the field.
Global Veterinary CRO and CDMO market is projected to reach US$ 10460 million in 2029, increasing from US$ 5800 million in 2022, with the CAGR of 8.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary CRO and CDMO market research.
The market growth is majorly propelled by factors, such as the wide adoption of veterinary outsourcing services owing to the therapeutic experience of Contract Development &Manufacturing Organizations (CDMO) and Contract Research Organizations (CRO), technical competence, high reliability, quality, & cost efficiency in outsourcing key processes of product development, and improved geographic convenience with local players. In addition, the on-time development & delivery of final products, coupled with the smooth introduction of novel veterinary drugs or devices into the market in compliance with specific regulatory standards, are boosting the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary CRO and CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Argenta Group (Klifovet)
Charles River Laboratories
Clinvet
IDEXX Laboratories
Inotiv
Knoell – Triveritas
Labcorp Drug Development
Oncovet Clinical Research (OCR)
Veterinary Research Management
Vetio
VETSPIN
Zoetis-Nexvet
Segment by Type
Contract Development &Manufacturing Organizations (CDMO)
Contract Research Organizations (CRO)
Segment by Application
Medicines
Medical Devices
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Veterinary CRO and CDMO report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
The key players operating in the animal health industry prefer contract outsourcing over in-house manufacturing, considering its associated benefits. Owing to the complex manufacturing processes of certain veterinary products, animal health drug or device manufacturers solely outsource key stages of production to expertise CROs and CDMOs. Outsourcing activities enable companies to reduce financial risk and encourage more developments & research in the field.
Global Veterinary CRO and CDMO market is projected to reach US$ 10460 million in 2029, increasing from US$ 5800 million in 2022, with the CAGR of 8.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary CRO and CDMO market research.
The market growth is majorly propelled by factors, such as the wide adoption of veterinary outsourcing services owing to the therapeutic experience of Contract Development &Manufacturing Organizations (CDMO) and Contract Research Organizations (CRO), technical competence, high reliability, quality, & cost efficiency in outsourcing key processes of product development, and improved geographic convenience with local players. In addition, the on-time development & delivery of final products, coupled with the smooth introduction of novel veterinary drugs or devices into the market in compliance with specific regulatory standards, are boosting the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary CRO and CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Argenta Group (Klifovet)
Charles River Laboratories
Clinvet
IDEXX Laboratories
Inotiv
Knoell – Triveritas
Labcorp Drug Development
Oncovet Clinical Research (OCR)
Veterinary Research Management
Vetio
VETSPIN
Zoetis-Nexvet
Segment by Type
Contract Development &Manufacturing Organizations (CDMO)
Contract Research Organizations (CRO)
Segment by Application
Medicines
Medical Devices
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Veterinary CRO and CDMO report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary CRO and CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Contract Development &Manufacturing Organizations (CDMO)
1.2.3 Contract Research Organizations (CRO)
1.3 Market by Application
1.3.1 Global Veterinary CRO and CDMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medicines
1.3.3 Medical Devices
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary CRO and CDMO Market Perspective (2018-2029)
2.2 Veterinary CRO and CDMO Growth Trends by Region
2.2.1 Global Veterinary CRO and CDMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Veterinary CRO and CDMO Historic Market Size by Region (2018-2023)
2.2.3 Veterinary CRO and CDMO Forecasted Market Size by Region (2024-2029)
2.3 Veterinary CRO and CDMO Market Dynamics
2.3.1 Veterinary CRO and CDMO Industry Trends
2.3.2 Veterinary CRO and CDMO Market Drivers
2.3.3 Veterinary CRO and CDMO Market Challenges
2.3.4 Veterinary CRO and CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary CRO and CDMO Players by Revenue
3.1.1 Global Top Veterinary CRO and CDMO Players by Revenue (2018-2023)
3.1.2 Global Veterinary CRO and CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary CRO and CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary CRO and CDMO Revenue
3.4 Global Veterinary CRO and CDMO Market Concentration Ratio
3.4.1 Global Veterinary CRO and CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary CRO and CDMO Revenue in 2022
3.5 Veterinary CRO and CDMO Key Players Head office and Area Served
3.6 Key Players Veterinary CRO and CDMO Product Solution and Service
3.7 Date of Enter into Veterinary CRO and CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary CRO and CDMO Breakdown Data by Type
4.1 Global Veterinary CRO and CDMO Historic Market Size by Type (2018-2023)
4.2 Global Veterinary CRO and CDMO Forecasted Market Size by Type (2024-2029)
5 Veterinary CRO and CDMO Breakdown Data by Application
5.1 Global Veterinary CRO and CDMO Historic Market Size by Application (2018-2023)
5.2 Global Veterinary CRO and CDMO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Veterinary CRO and CDMO Market Size (2018-2029)
6.2 North America Veterinary CRO and CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Veterinary CRO and CDMO Market Size by Country (2018-2023)
6.4 North America Veterinary CRO and CDMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary CRO and CDMO Market Size (2018-2029)
7.2 Europe Veterinary CRO and CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Veterinary CRO and CDMO Market Size by Country (2018-2023)
7.4 Europe Veterinary CRO and CDMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary CRO and CDMO Market Size (2018-2029)
8.2 Asia-Pacific Veterinary CRO and CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Veterinary CRO and CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Veterinary CRO and CDMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary CRO and CDMO Market Size (2018-2029)
9.2 Latin America Veterinary CRO and CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Veterinary CRO and CDMO Market Size by Country (2018-2023)
9.4 Latin America Veterinary CRO and CDMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary CRO and CDMO Market Size (2018-2029)
10.2 Middle East & Africa Veterinary CRO and CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Veterinary CRO and CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Veterinary CRO and CDMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Argenta Group (Klifovet)
11.1.1 Argenta Group (Klifovet) Company Detail
11.1.2 Argenta Group (Klifovet) Business Overview
11.1.3 Argenta Group (Klifovet) Veterinary CRO and CDMO Introduction
11.1.4 Argenta Group (Klifovet) Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.1.5 Argenta Group (Klifovet) Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Veterinary CRO and CDMO Introduction
11.2.4 Charles River Laboratories Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.2.5 Charles River Laboratories Recent Development
11.3 Clinvet
11.3.1 Clinvet Company Detail
11.3.2 Clinvet Business Overview
11.3.3 Clinvet Veterinary CRO and CDMO Introduction
11.3.4 Clinvet Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.3.5 Clinvet Recent Development
11.4 IDEXX Laboratories
11.4.1 IDEXX Laboratories Company Detail
11.4.2 IDEXX Laboratories Business Overview
11.4.3 IDEXX Laboratories Veterinary CRO and CDMO Introduction
11.4.4 IDEXX Laboratories Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.4.5 IDEXX Laboratories Recent Development
11.5 Inotiv
11.5.1 Inotiv Company Detail
11.5.2 Inotiv Business Overview
11.5.3 Inotiv Veterinary CRO and CDMO Introduction
11.5.4 Inotiv Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.5.5 Inotiv Recent Development
11.6 Knoell – Triveritas
11.6.1 Knoell – Triveritas Company Detail
11.6.2 Knoell – Triveritas Business Overview
11.6.3 Knoell – Triveritas Veterinary CRO and CDMO Introduction
11.6.4 Knoell – Triveritas Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.6.5 Knoell – Triveritas Recent Development
11.7 Labcorp Drug Development
11.7.1 Labcorp Drug Development Company Detail
11.7.2 Labcorp Drug Development Business Overview
11.7.3 Labcorp Drug Development Veterinary CRO and CDMO Introduction
11.7.4 Labcorp Drug Development Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.7.5 Labcorp Drug Development Recent Development
11.8 Oncovet Clinical Research (OCR)
11.8.1 Oncovet Clinical Research (OCR) Company Detail
11.8.2 Oncovet Clinical Research (OCR) Business Overview
11.8.3 Oncovet Clinical Research (OCR) Veterinary CRO and CDMO Introduction
11.8.4 Oncovet Clinical Research (OCR) Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.8.5 Oncovet Clinical Research (OCR) Recent Development
11.9 Veterinary Research Management
11.9.1 Veterinary Research Management Company Detail
11.9.2 Veterinary Research Management Business Overview
11.9.3 Veterinary Research Management Veterinary CRO and CDMO Introduction
11.9.4 Veterinary Research Management Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.9.5 Veterinary Research Management Recent Development
11.10 Vetio
11.10.1 Vetio Company Detail
11.10.2 Vetio Business Overview
11.10.3 Vetio Veterinary CRO and CDMO Introduction
11.10.4 Vetio Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.10.5 Vetio Recent Development
11.11 VETSPIN
11.11.1 VETSPIN Company Detail
11.11.2 VETSPIN Business Overview
11.11.3 VETSPIN Veterinary CRO and CDMO Introduction
11.11.4 VETSPIN Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.11.5 VETSPIN Recent Development
11.12 Zoetis-Nexvet
11.12.1 Zoetis-Nexvet Company Detail
11.12.2 Zoetis-Nexvet Business Overview
11.12.3 Zoetis-Nexvet Veterinary CRO and CDMO Introduction
11.12.4 Zoetis-Nexvet Revenue in Veterinary CRO and CDMO Business (2018-2023)
11.12.5 Zoetis-Nexvet Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
